Ultimele actualizari :
19/11/2024
Bibliografie   Bibliografie 4545  
tip : ziar
Internet legătură într- : 10.1272/jnms.JNMS.2022_89-104

Echipe de cercetare : Tokyo - Nippon Medical School Hospital, Department of Pharmacy
Autor : Kondo M, Nagano M, Yoshida M, Yoshida N, Tagui N, Yoshida M, Sugaya K, Takase H.
titlu : Physical compatibility of nafamostat with analgesics, sedatives, and muscle relaxants for coronavirus disease treatment.
Référence : Journal of Nippon Medical school 2021

Nivelul dovezii : 
stabilitatea fizică : 
Stabilitate chimică : 
alte metode : 
Comentarii : 

Listele
InjectabilDexmedetomidine Simpatomimetic
Compatibil 4 µg/ml + InjectabilNafamostat 10 mg/mL + Glucoza 5%
InjectabilFentanyl citrate Antialgic
Compatibil 50 µg/ml + InjectabilNafamostat 10 mg/mL + Glucoza 5%
InjectabilMidazolam hydrochloride Anxiolitic
Compatibil 5 mg/ml + InjectabilNafamostat 10 mg/mL + Glucoza 5%
InjectabilMorphine hydrochloride Antialgic
Compatibil 2 mg/ml + InjectabilNafamostat 10 mg/mL + Glucoza 5%
InjectabilNafamostat Anticoagulant
Compatibil 10 mg/mL + InjectabilDexmedetomidine 4 µg/ml + Glucoza 5%
Compatibil 10 mg/mL + InjectabilFentanyl citrate 50 µg/ml + Glucoza 5%
Compatibil 10 mg/mL + InjectabilMidazolam hydrochloride 5 mg/ml + Glucoza 5%
Compatibil 10 mg/mL + InjectabilMorphine hydrochloride 2 mg/ml + Glucoza 5%
Compatibil 10 mg/mL + InjectabilRocuronium bromide 10 mg/ml + Glucoza 5%
InjectabilRocuronium bromide Curarizant
Compatibil 10 mg/ml + InjectabilNafamostat 10 mg/mL + Glucoza 5%

  Mentions Légales